Document And Entity Information Note To Financial Statement Details Textual Significant Accounting Policies us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities Payments of Contingent consideration Note 1 - Basis of Presentation and Summary of Significant Accounting Policies Contingent Consideration [Member] Liabilities that are contingent on agreed-upon conditions that arise from business combinations. Other comprehensive income: London Interbank Offered Rate (LIBOR) [Member] Note 2 - Selected Balance Sheet Data us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Note 3 - Acquisitions Note 4 - Fair Value Measurements Note 6 - Accumulated Other Comprehensive Income Variable Rate [Domain] Note 7 - Earnings Per Share Operating expenses: Variable Rate [Axis] Note 9 - Other Income (Expense) Note 11 - Segment Information Federal Funds Effective Swap Rate [Member] Note 1 - Basis of Presentation and Summary of Significant Accounting Policies - Revision of Unaudited Consolidated Financial Statements (Details) Note 2 - Selected Balance Sheet Data - Inventories (Details) Note 2 - Selected Balance Sheet Data - Property and Equipment (Details) Note 2 - Selected Balance Sheet Data - Intangible Assets (Details) Note 2 - Selected Balance Sheet Data - Changes to Carrying Amount of Net Intangible Assets (Details) Note 2 - Selected Balance Sheet Data - Estimated Future Amortization Expense for Intangible Assets (Details) Note 2 - Selected Balance Sheet Data - Changes in Carrying Amount of Goodwill (Details) Note 2 - Selected Balance Sheet Data - Other Assets (Details) us-gaap_AvailableForSaleSecurities Available-for-sale Securities Note 3 - Acquisitions - Fair Value of Assets and Liabilities Assumed (Details) us-gaap_PaymentsOfDividendsCommonStock Cash dividends tech_PaymentForContingentConsiderationLiability Payment for Contingent Consideration Liability The total amount of cash outflow for the acquisition of business combination, to settle contingent consideration liability. Includes the operating and financing activities. Note 4 - Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) Note 4 - Fair Value Measurements - Liability Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details) Note 6 - Accumulated Other Comprehensive Income - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) Note 7 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) Unrealized gains and losses on availiable-for-sale investments, net of tax Adjustments to fair value, cash paid, net of cash acquired Note 9 - Other Income (Expense) - Schedule of Components of Other Income (Expense) (Details) Note 11 - Segment Information - Financial Information Relating to Reportable Segments (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles Adjustments to fair value, intangible assets Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 [Member] us-gaap_LineOfCredit Long-term Line of Credit Other operating activity Fair Value Hierarchy [Domain] Proceeds from stock option exercises Cash dividends per common share: (in dollars per share) Fair Value, Hierarchy [Axis] CASH FLOWS FROM INVESTING ACTIVITIES: Short-term available-for-sale investments Equity Component [Domain] Equity Components [Axis] Income taxes payable us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable Changes in income tax payable us-gaap_CostMethodInvestments Investments us-gaap_ComprehensiveIncomeNetOfTax Comprehensive income (loss) Comprehensive income us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Liabilities Arising from Contingencies, Amount Recognized Trade accounts payable and accrued expenses Salaries, wages and related accruals us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities Changes in salaries, wages and related accruals Supplemental Balance Sheet Disclosures [Text Block] us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity Fair value adjustment to contingent consideration payable Common stock outstanding (in shares) us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage New Accounting Pronouncements, Policy [Policy Text Block] Investments by Category [Axis] Asset Class [Axis] Marketable Securities and Investments Held at Cost [Domain] Asset Class [Domain] Diluted (in shares) us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Long-term debt obligations us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Net assets acquired us-gaap_AvailableForSaleEquitySecuritiesAmortizedCostBasis Available-for-sale Equity Securities, Amortized Cost Basis Equity Securities [Member] us-gaap_LineOfCreditFacilityExpirationDate1 Line of Credit Facility, Expiration Date Subsequent Event [Member] Deferred income taxes, net Diluted (in dollars per share) Subsequent Event Type [Domain] Subsequent Event Type [Axis] Net sales Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Subsequent Events [Text Block] Liabilities Restatement Adjustment [Member] Scenario, Previously Reported [Member] Machinery and Equipment [Member] Basic (in shares) Weighted-average shares outstanding – basic (in shares) Basic (in dollars per share) Scenario, Unspecified [Domain] Selling, General and Administrative Expenses [Member] Equipment and other long-term assets Scenario, Forecast [Member] Scenario [Axis] Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Intangible assets Debt Disclosure [Text Block] us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets Current assets, net of cash Advanced Cell Diagnostics (ACD) [Member] Represents Advanced Cell Diagnostics (ACD), a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities Segment Reconciling Items [Member] Income Statement Location [Domain] Cash paid, net of cash acquired Business Combination, Consideration Transferred Consolidation Items [Domain] Income Statement Location [Axis] Consolidation Items [Axis] Intersegment Eliminations [Member] Borrowings under line-of-credit agreement Operating Segments [Member] Maximum [Member] Range [Domain] Minimum [Member] Range [Axis] Accounting Policies [Abstract] Statement of Financial Position [Abstract] us-gaap_IncreaseDecreaseInPrepaidExpense Prepaid expenses us-gaap_BusinessCombinationContingentConsiderationLiability Contingent Consideration Investment, Name [Domain] Trevigen Inc. [Member] Information pertaining to Trevigen Inc. Statement of Cash Flows [Abstract] Fair Value by Liability Class [Domain] Liability Class [Axis] Investment, Name [Axis] Costs recognized on sale of acquired inventory The noncash expense during the period from the sale of acquired inventory written up to fair value in purchase accounting. us-gaap_RepaymentsOfLinesOfCredit Payments on line-of-credit us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Stock based compensation us-gaap_AvailableForSaleSecuritiesGrossRealizedLosses Available-for-sale Securities, Gross Realized Losses us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Change in fair value of contingent consideration Schedule of Intangible Assets and Goodwill [Table Text Block] us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables Trade accounts and other receivables Geographical [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Investment [Axis] Tax Credit Carryforward [Axis] Geographical [Axis] Long-term contingent consideration payable Tax Credit Carryforward, Name [Domain] Other long-term liabilities Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Trade Names [Member] Deferred income taxes us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders’ equity Investment [Domain] us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent Income tax expense (benefit) Retained earnings Accumulated other comprehensive loss Segments [Axis] Segments [Domain] us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_IncreaseDecreaseInInventories Inventories Corporate Debt Securities [Member] us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair value at the beginning of period Fair value at the end of period Credit Facility [Domain] Statement [Table] Revolving Credit Facility [Member] Available-for-sale Securities [Member] Credit Facility [Axis] Noncompete Agreements [Member] us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Payments Income Statement [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: us-gaap_AccruedIncomeTaxesNoncurrent Accrued Income Taxes, Noncurrent Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Developed Technology Rights [Member] Patents [Member] Class of Stock [Axis] Award Type [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Equity Award [Domain] Biotechnology [Member] Information about the company's Biotechnology segment. Customer Relationships [Member] Protein Platforms [Member] Information about the company's Protein Platforms segment. us-gaap_OtherAssetsMiscellaneousNoncurrent Other tech_LineOfCreditFacilityAdditionalBorrowingCapacity Line of Credit Facility, Additional Borrowing Capacity The element representing the additional borrowing capacity under a line of credit. CyVek, Inc. [Member] Information concerning, or mentioned in connection with, the entity CyVek, Inc. Finite-Lived Intangible Assets, Major Class Name [Domain] Segment Reporting Disclosure [Text Block] Schedule of Other Assets, Noncurrent [Table Text Block] Finite-Lived Intangible Assets by Major Class [Axis] us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent CHINA Prepaid expenses and other Atlanta Biologicals [Member] Represents information pertaining Atlanta Biologicals. us-gaap_PaymentsToAcquireInterestInJointVenture Purchase of equity investment us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired Acquisitions, net of cash acquired us-gaap_LiabilitiesCurrent Total current liabilities tech_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRevaluationOfContingentConsideration Effective Income Tax Rate Reconciliation, Nondeductible Expense, Revaluation of Contingent Consideration Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expense related to the revaluation of contingent consideration. Raw materials us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent Contingent consideration payable Finished goods Other income (expense) Other (expense) income Total other income (expense) Other non-operating income (expense), net us-gaap_OperatingExpenses Total operating expenses Zephyrus [Member] Information about Zephyrus. Change in operating assets and operating liabilities, net of acquisition: Adjustments to fair value, goodwill Goodwill, Purchase Accounting Adjustments tech_IncomeTaxExpenseBenefitDiscreteTaxItems Income Tax Expense (Benefit), Discrete Tax Items Represents the income tax expense (benefit) related to discrete tax items. Property, Plant and Equipment [Table Text Block] us-gaap_GoodwillForeignCurrencyTranslationGainLoss Currency translation us-gaap_InvestmentIncomeNet Interest income Certificates Of Deposit [Member] Information pertaining to certificates of deposits. ChemoCentryx, Inc (CCXI) [Member] Represents ChemoCentryx, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer primarily focused on orphan and rare diseases. us-gaap_GoodwillAcquiredDuringPeriod Acquisitions (Note 3) Operating income Operating income Deferred revenue Schedule of Inventory, Current [Table Text Block] Business Combination Disclosure [Text Block] Deferred income taxes us-gaap_DeferredIncomeTaxExpenseBenefit us-gaap_GrossProfit Gross margin Amendment Flag Thereafter Common stock, par value $.01 per share; authorized 100,000,000; issued and outstanding 37,469,896 and 37,356,041, respectively Cost of sales 2020 2019 2022 2021 2018 us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess tax benefit from stock option exercises Common stock authorized (in shares) Common stock issued (in shares) Other assets Other Assets, Noncurrent Other assets Common stock par value (in dollars per share) Income Tax Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Stock-based compensation expense us-gaap_ShareBasedCompensation us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Fair Value, Measurement Inputs, Disclosure [Text Block] Proceeds from maturities of available-for-sale investments Current Fiscal Year End Date Document Fiscal Period Focus Astute Medical, Inc. [Member] The acquired investment of Astute Medical, Inc. Document Fiscal Year Focus tech_FinitelivedIntangibleAssetsOtherAdditions Other additions Amount of other additions lacking physical substance with a definite life. Document Period End Date us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-Lived Intangible Asset, Useful Life us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Document Type us-gaap_BusinessCombinationAcquisitionRelatedCosts Acquisition related expenses Income taxes payable Accrued Income Taxes, Current us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other comprehensive income (loss) Other comprehensive (loss) income us-gaap_PaymentsToAcquireInvestments Payments to Acquire Investments us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss Currency translation Depreciation and amortization us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Trade accounts payable Document Information [Line Items] Document Information [Table] Salaries, wages and related accruals us-gaap_AssetsCurrent Total current assets Accrued expenses us-gaap_GoodwillImpairmentLoss Goodwill, Impairment Loss Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Entity Filer Category us-gaap_FinitelivedIntangibleAssetsAcquired1 Acquisitions Entity Current Reporting Status Schedule of Finite-Lived Intangible Assets [Table Text Block] Entity Voluntary Filers Entity Well-known Seasoned Issuer us-gaap_PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities Purchases of available-for-sale investments us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price tech_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentAssetsNetOfCash Adjustments to fair value, current assets, net of cash This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to current assets (net of cash) acquired in connection with a business combination for which the initial accounting was incomplete. us-gaap_AmortizationOfIntangibleAssets Amortization of acquisition related intangible assets Amortization expense Adjustments to fair value, total assets acquired This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to all assets acquired (including goodwill) in connection with a business combination for which the initial accounting was incomplete. Adjustments to fair value, liabilities This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to liabilities assumed in connection with a business combination for which the initial accounting was incomplete. Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to fair value, equipment and other long-term assets This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to equipment and other long-term assets acquired in connection with a business combination for which the initial accounting was incomplete. Dilutive effect of stock options and restricted stock units (in shares) Acquisition Related [Member] The expenses related to acquisitions. Entity Central Index Key Eurocell Diagnostics, SAS [Member] Represents information pertaining Eurocell Diagnostics, SAS Entity Registrant Name tech_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentsNewLegislation Income Tax Expense (Benefit), Continuing Operations, Adjustments, New Legislation Represents the total amount of adjustments on income taxes related to newly enacted legislation. Adjustments to fair value, deferred income taxes, net This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to deferred income tax liabilities assumed in connection with a business combination for which the initial accounting was incomplete. tech_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssets Adjustments to fair value, net assets acquired This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to assets (net liabilities) acquired in connection with a business combination for which the initial accounting was incomplete. Total Assets Entity [Domain] Transition Tax [Member] Information regarding the transition tax. Legal Entity [Axis] Weighted average common shares outstanding: tech_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentsOnTransitionTax Income Tax Expense (Benefit), Continuing Operations, Adjustments on Transition Tax The amount of adjustments recognized on income tax expense (benefit) for adjustments on transition tax. Total assets acquired Amount of assets acquired, including goodwill, at the acquisition date. Current liabilities: Schedule of Goodwill [Table Text Block] us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Income available to common shareholders Schedule of Other Nonoperating Income (Expense) [Table Text Block] Entity Common Stock, Shares Outstanding (in shares) Cash paid for income taxes Corporate securities us-gaap_InvestmentsFairValueDisclosure us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted Income available to common shareholders LIABILITIES AND SHAREHOLDERS' EQUITY us-gaap_Assets Total assets Additional paid-in capital Cash paid for interest Inventories Inventories, net us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Income allocated to participating securities Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Trading Symbol Comprehensive Income (Loss) Note [Text Block] Other Income and Other Expense Disclosure [Text Block] us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment Net earnings Net earnings Net income Business Description and Accounting Policies [Text Block] us-gaap_StockholdersEquity Total shareholders' equity Beginning balance Ending balance Selling, general and administrative Corporate general, selling, and administrative expenses us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized us-gaap_NumberOfReportingUnits Number of Reporting Units us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Restricted Stock Units (RSUs) [Member] us-gaap_CostOfGoodsSold Costs recognized on sale of acquired inventory Restricted Stock [Member] Intangible assets, net Intangible assets, net Beginning balance Ending balance us-gaap_FiniteLivedIntangibleAssetsNet Total Diagnostics [Member] Represents the company's Diagnostics segment, a segment was focused on controls and calibrators for hematology clinical instruments. CASH FLOWS FROM OPERATING ACTIVITIES: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Accumulated amortization us-gaap_FiniteLivedIntangibleAssetsGross Intangible assets Accounts receivable, allowance for doubtful accounts Accounts receivable, less allowance for doubtful accounts of $905 and $696, respectively Statement [Line Items] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Research and development Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] us-gaap_InterestExpense Interest expense Supplemental disclosure of cash flow information: AOCI Attributable to Parent [Member] Unrealized gain (loss) on available-for-sale investments, net of tax of $799, $(1,889), $5,375, and $(2,060), respectively Goodwill Beginning balance Ending balance Current assets: Property and equipment, net Property and equipment, net ASSETS us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated depreciation and amortization Property and equipment, cost Foreign currency translation adjustments Advance Cell Diagnostics (ACD), Zephyrus, and CyVek Inc.[Member] Represents the acquisitions of Advance Cell Diagnostics (ACD), Zephyrus, and CyVek, Inc. us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash (used in) provided by financing activities us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Building and Building Improvements [Member] us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash used in investing activities us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by operating activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase (decrease) in cash and cash equivalents us-gaap_TableTextBlock Notes Tables Effect of exchange rate changes on cash and cash equivalents Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Axis] Land [Member] Earnings before income taxes Shareholders' equity: Other financing Business Acquisition, Acquiree [Domain] Earnings Per Share [Text Block] Business Acquisition [Axis] Earnings per share: